000 02423nam a2200541 i 4500
005 20250919085947.0
006 m e d
007 cr cn |||m|||a
008 170131s2011 enka ob 001 0 eng
020 _a9781780840345 (PDF)
020 _a9781780840352 (ePub)
020 _z9781780841175 (print)
040 _dUKM
_erda
090 _aebook PHCTM
245 0 0 _aAdvances in personalized therapy for lung cancer /
_ceditor, Nagahiro Saijo.
264 1 _aLondon :
_bFuture Medicine Ltd ,
_c2011.
300 _a1 electronic text (67 pages) :
_bcolor illustrations, digital file.
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
490 1 _aThe Future Science Group eBook collection,
_x2047-332X
504 _aIncludes bibliographical references and index.
505 0 _aAdvances in personalized therapy for lung cancer / Nagahiro Saijo -- Biomarkers in lung cancer / Tobenna Nwizu & Ravi Salgia -- EGF receptor-targeted drugs / Tetsuya Mitsudomi -- Antiangiogenic therapies for non-small-cell lung cancer / Suresh S. Ramalingam & Chandra P. Belani -- DNA-targeted drugs / Judith Meza-Junco & Michael B. Sawyer.
506 _aRestricted to subscribers or individual electronic text purchasers.
530 _aAlso available in print.
538 _aMode of access: World Wide Web.
538 _aSystem requirements: Adobe Acrobat Reader.
588 _aTitle from PDF title page (Future Medicine eBooks Web site, viewed November 17, 2011).
650 0 _aLungs
_xcancer
_xTreatment.
650 0 _aLungs
_xCancer
_xChemotherapy.
650 0 _aLungs
_xCancer
_xMolecular aspects.
650 1 2 _aLung Neoplasms
_xtherapy.
650 1 2 _aLung Neoplasms
_xdrug therapy.
650 1 2 _aAngiogenesis Inhibitors
_xtherapeutic use.
655 0 _aElectronic books.
700 1 _aSaijo, Nagahiro.
710 2 _aFuture Medicine Ltd.
773 0 _aFuture Medicine
776 0 8 _iPrint version:
_z9781780841175
830 0 _aFuture Science Group eBook collection,
_x2047-332X.
856 4 0 _uhttps://www-futuremedicine-com.eresourcesptsl.ukm.remotexs.co/doi/epdf/10.2217/9781780840345
856 4 0 _uhttps://doi.org/10.2217/9781780840345
907 _a.b16423434
_b2023-07-13
_c2019-11-12
942 _c01
_n0
_kebook PHCTM
914 _avtls003616537
998 _ah
_b2017-05-01
_cm
_dz
_feng
_genk
_y0
_z.b16423434
999 _c615608
_d615608